Satiety and amino-acid profile in overweight women after a new treatment using a natural plant extract sublingual spray formulation

International Journal of Obesity

Volumn 33, Issue 10, 2009, Pages 1174-1182

  Rondanelli, M ^a   Klersy, C ^b   Iadarola, P ^a   Monteferrario, F ^a   Opizzi, A ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

5 hydroxytryptophan; Appetite; Satiety; Sublingual drug delivery spray formulation; Weight loss

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; AMINO ACID; HERBACEOUS AGENT; PLACEBO; ANOREXIGENIC AGENT; DRUG DOSAGE FORM; PLANT EXTRACT;

ADULT; ANOREXIA; ARTICLE; BINGE EATING DISORDER; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG FORMULATION; DRUG SAFETY; FEMALE; FOOD INTAKE; HUMAN; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SATIETY; SINGLE BLIND PROCEDURE; SKINFOLD THICKNESS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION; VISUAL ANALOG SCALE; BIOAVAILABILITY; BLOOD; DRUG ADMINISTRATION; DRUG DOSAGE FORM; DRUG EFFECTS; LOW CALORY DIET; METABOLISM; MIDDLE AGED; OVERWEIGHT; PHYSIOLOGY; PSYCHOLOGY; WEIGHT REDUCTION;

5-HYDROXYTRYPTOPHAN; ADULT; AMINO ACIDS; APPETITE DEPRESSANTS; APPETITE REGULATION; BIOLOGICAL AVAILABILITY; DIET, REDUCING; DOSAGE FORMS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; OVERWEIGHT; PLANT EXTRACTS; SATIATION; WEIGHT LOSS;

EID: 70349971886     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.155     Document Type: Article

References (55)

1. Blundell JE, Leshem MB. The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine. J Pharm Pharmacol 975; 27: 3l-37.
2. Leibowitz SF. The role of serotonin in eating disorders. Drugs Suppl 1990; 39: 33-48.
3. Ashley DV, Coscina DV, Anderson GH. Selective decrease in protein intake following brain serotonin depletion. Life Sci 1979; 24: 973-984.
4. Haleem DJ. Exaggerated feedback control decreases brain serotonin concentration and elicits hyperactivity in a rat model of diet-restriction- induced anorexia nervosa. Appetite 2009; 52: 44-50.
5. Shor-Posner G, Grinker JA, Marinescu C, Brown O, Leibowitz SF. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull 1986; 17: 663-671. (Pubitemid 17200136)
6. Pijl H, Koppeschaar HP, Iestra JA, Schoemaker HC, Frölich M, Onkenhout W et al. Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans. Int J Obes Relat Metab Disord 1993; 17: 513-520.
7. Markus CR, Panhuysen G, Tuiten A, Koppeschaar H, Fekkes D, Peters ML. Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite 1998; 31: 49-65.
8. Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O'Rahilly S et al. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 2008; 149: 1323-1328.
9. Silverstone T, Goodall E. Serotoninergic mechanisms in human feeding: the pharmacological evidence. Appetite Suppl 1986; 7: 85-97.
10. Curzon G. Serotonin and appetite. Ann NY Acad Sci 1990; 600: 521-530.
11. Sze JY, Victor M, Loer C, Shi Y, Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 2000; 403: 560-564.
12. Vickers SP, Clifton PG, Dourish CT, Tecott LH. Reduced satiating effect of D-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology 1999; 143: 309-314.
13. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 1972; 178: 414-416.
14. Pardridge WM, Oldendorf WH. Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta 1975; 401: 128-136.
15. Fernstrom JD. Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1990; 1: 508-517.
16. Fernstrom MH, Fernstrom JD. Brain tryptophan concentrations and serotonin synthesis remain responsive to food consumption after the ingestion of sequential meals. Am J Clin Nutr 1995; 61: 312-319.
17. Caballero B, Finer N, Wurtman RJ. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements. Metabolism 1988; 37: 672-676.
18. Ashley DV, Fleury MO, Golay A, Maeder E, Leathwood PD. Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr 1985; 42: 1240-1245.
19. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr 2003; 77: 1112-1118.
20. Breum L, Moller SE, Andersen T, Astrup A. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss. Int J Obes Relat Metab Disord 1996; 20: 147-153.
21. Gatti E, Porrini M, Noè D, Crovetti R, Testolin G. Plasma amino acid changes in obese patients on very low-calorie diets. Int J Vitam Nutr Res 1994; 64: 81-85.
22. Goodwin GM, Cowen PJ, Fairburn CG, Parry-Billings M, Calder PC, Newsholme EA. Plasma concentrations of tryptophan and dieting. BMJ 1990; 300: 1499-1500.
23. Wolfe BE, Metzger ED, Stollar C. The effects of dieting on plasma tryptophan concentration and food intake in healthy women. Physiol Behav 1997; 61: 537-541.
24. Attenburrow MJ, Williams C, Odontiadis J, Powell J, Van de Ouderaa F, Williams M et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function. Psychol Med 2003; 33: 1381-1386.
25. Jeffery RW, Drewnowski A, Epstein LH, Stunkard AJ, Wilson GT, Wing RR et al. Long-term maintenance of weight loss: current status. Health Psychol 2000; 19: 5-16.
26. Fernstrom ID. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 1983; 63: 484-546.
27. Ceci F, Cangiano C, Cairella M, Cascino A, Del Ben M, Muscaritoli M et al. The effects of oral 5-hydroxytryptophan administration on feeding behaviour in obese adult female subjects. J Neural Transm 1989; 76: 109-117.
28. Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M et al. Eating behaviour and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992; 56: 863-867.
29. Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection for in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord 1998; 22: 648-654.
30. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A, Westerterp KR, Engelen MP, Brummer RJ et al. A breakfast with alpha-lactalbumin, gelatin, or gelatin + TRP lowers energy intake at lunch compared with a breakfast with casein, soy, whey, or whey-GMP. Clin Nutr 2009; 28: 147-155.
31. Yamada J, Sugimoto Y, Ujikawa M. Involvement of leptin in hypophagia induced by the serotonin precursor 5-hydroxytryp-tophan (5-HTP) in mice. Biol Pharm Bull 2006; 29: 557-559.
32. Yamada J, Sugimoto Y, Ujikawa M. The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice. Eur J Pharmacol 1999; 383: 49-51.
33. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998; 18: 399-419.
34. Kurosaki Y, Takatori T, Nishimura H, Nakayama T, Kimura T. Regional variation in oral mucosal drug absorption permeability and degree of keratinization in hamster oral cavity Pharm Res 1991 8 1297-1301
35. Tuner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytrypto-phan. Pharmacol Ther 2006; 109: 325-338.
36. Lemaire PA, Adosraku RK. An HPLC method for the direct assay of the serotonin precursor, 5-hydroxytrophan, in seeds of Griffonia simplicifolia. Phytochem Anal 2002; 13: 333-337.
37. Lima WP, Carnevali Jr LC, Eder R, Costa Rosa LF, Bacchi EM, Seelaender MC. Lipid metabolism in trained rats: effect of guaranà (Paullinia cupana Mart.) supplementation. Clin Nutr 2005; 24: 1019-1028.
38. Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacolo and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine 2000; 7: 427-448.
39. Schütz K, Carle R, Schieber A. TaraxacumFa review on its phyto-chemical and pharmacological profile. J Ethnopharmacol 2006; 107: 313-323.
40. Moglia A, Lanteri S, Comino C, Acquadro A, de Vos R, Beekwilder J. Stress-induced biosynthesis of dicaffeoylquinic acids in globe artichoke. J Agric Food Chem 2008; 56: 8641-8649.
41. Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 781-823.
42. American Psychiatric Association. Mood disorders. In: American Psychiatric Association (eds) Diagnostic and Statistical Manual of Mental Disorders 4th edn American Psychiatric Association: Washington, DC, 1994. pp 317-345.
43. Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol 1989; 161: 1228-1234.
44. Haber GB, Heaton KW, Murphy D, Burroughs LF. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet 1977; 2: 679-682.
45. Udenfriend S, Titus E, Weissabach H. The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J Biol Chem 955; 2l6: 449-505.
46. Frisancho AR. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 1984; 40: 808-819.
47. World Health Organization. Energy and Protein Requirements Report of a Joint FAO/WHO/UNU Expert Consultation. WHO Technical Report Series No.724 WHO: Geneva, Switzerland, 1985.
48. Gormally J, Black S, Daston S, Rardin D. The assessment of binge eating severity among obese persons. Addict Behav 1982; 7: 47-55.
49. Steer RA, Ball R, Ranieri WF, Beck AT. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 1999; 55: 117-128.
50. Ware JE, Snow KK, Kosinski M, Gandek B (eds). SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute: Boston, MA 1993
51. Das YT, Bagchi M, Bagchi D, Preuss HG. Safety of 5-hydroxy-L-tryptophan. Toxicol Lett 2004; 150: 111-122.
52. Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel SW, Herrera Ruiz D, Torres E. Risk and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol 2008; 227: 125-135.
53. Pittler MH, Thompson CO, Ernst E. Artichoke leaf extract for treating hypercholesterolemia. Cochrane Database Syst Rev 2002; 3: CD003335.
54. Doucet E, Imbeault P, St-Pierre S, Alméras N, Mauriège P, Richard D. Appetite after weight loss by energy restriction and low-fat diet exercise follow up. Int J Obes Relat Metab Disord 2000; 24: 906-914.
55. Pathan SA, Iqbal Z, Sahani JK, Talegaonkar S, Khar RK, Ahmad FJ. Buccoadhesive drug delivery systemsFextensive review on recent patents. Recent Pat Drug Deliv Formul 2008; 2: 177-188.